Skip to main content

Table 1 Baseline patient’s characteristics

From: Bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: a meta-analysis

  Abellas et al. 2017 Azzalini et al. 2016 Fam et al. 2017 Goktekin et al. 2015 Kugler et al. 2017 Lesiak et al. 2016 Mitomo et al. 2016 Ojeda et al. 2015 Ozel et al. 2016 Saad et al. 2016 Vaquerizo et al. 2016 Wiebe et al. 2015 Yamac et al. 2017
Age (years) 59.2 ± 8.7 60.0 ± 9.3 59.40 ± 8.96 56.9 ± 9.4 60.5 ± 7.8 59.9 ± 8.3 60.8 ± 11.0 58 ± 9 61.9 ± 9.7 65.3 ± 10.9 61 ± 10 60.4 ± 9.0 57.8 ± 9.6
Male (%) 89.5 89.5 90.0 85.7 77.5 89.2 98 85.4 75 80 81.8 86.7
Hypertension (%) 44.4 65.4 69.5 78.6 64.3 80 67.8 57 80.5 78.6 91.3 80
Diabetes (%) 22.2 34.0 33.3 21.4 14.3 30 40 33 51.2 26.3 20 34.8 3.3
Smoking (%) 77.8 24.8 48.6 35.7 57.1 35 8 34.1 41.5 47.8 40
Family History (%) 29.6 21.9 32.9 30.8 33.3
Hyperlipidemia (%) 100 69.9 72.4 52.9 71.4 61.5 64 46.3 50.4 65.2 56.7
Prior CABG (%) 2.6 2.9 10 0 5 6.2 17.1 2.7 6.7
Prior PCI (%) 43.8 46.7 17.1 45 53.8 36 56.1 39.3 13.3
Prior stroke/TIA (%) 0 2.6 0 30.8 0
CKD (%) 5.5 2 7.1 15 40.1 0 0
LVEF (%) 53.2 ± 10.1 51.7 ± 6.7 50.7 ± 10.2 57.7 ± 10.8 54 ± 8 59.8 ± 13.8 55.7 ± 15.5 50.2 ± 6.4